New drugs 'delayed to cut costs' says GSK boss

 

The head of Britain biggest drugs company has accused the Government of systematically delaying the introduction of new cancer drugs in order to save money.

GLaxoSmithKline chief executive Sir Andrew Witty warned that ministers were making false economies as they tried to grapple with the deficit in the public finances.

In an interview with the BBC, he said that governments across Europe had already cut drug prices by 5% a year - costing GSK around £300 million per annum.

However, he said governments were now seeking to go further in an effort to achieve even bigger savings - and he highlighted Britain's decision to delay new cancer treatments.

"The bit I'm much more frightened about is that what's now beginning to become clear is that, in addition to price reductions, governments are delaying the approval of innovative new drugs," he said.

"So a second way they can save money, they think, is 'Let's just not buy the next round of innovation'.

"Cancer in the UK is a good example where we're seeing oncology drugs being systematically delayed from introduction and reimbursement.

"We are seeing a variety of the more innovative and more expensive medicines being delayed in a whole series of different diseases across Europe."

Sir Andrew accused governments of treating the pharmaceuticals industry as a "simple procurement business" without understanding the wider implications of their decisions.

"As governments have got more and more anxious about their debt positions and austerity agendas, what happened is quite predictable," he said.

"If you are a minister and you need to cut costs, it is a lot easier to cut drug prices than it is to close a hospital or reduce the size of the Civil Service. I understand that.

"The issue here is, of course, if you don't buy the new drug it is going to save you money in the drug bill. But the drug bill is only 8% to 10% of the total healthcare bill and what is being lost in this stampede for cost cut is any kind of strategic thoughtfulness."

Professor Jonathan Waxman, of Imperial College London, said a number of new cancer drugs had been blocked by the National Institute for Health and Clinical Excellence (Nice), which assesses the cost-effectiveness of new treatments.

"In my view, Nice has over-regulated and proscribed drugs that offer real advances to people with cancer," he told the BBC Radio 4 Today programme.

"In my particular area of specialisation, which is prostate cancer, we have had two new drugs become available over the last year and a half which offer real benefits for patients.

"I would argue that they have been disallowed - banned - by Nice on the basis of an assessment which is not a true financial costing of the worth of the drugs."

He warned that drug companies may soon no longer find it worthwhile to seek approval for their products in Britain.

"The regulation is such in this country that it is not worthwhile for the drug companies making the effort of actually negotiating with our regulatory authorities for the sale of their products in the UK. It is a complete loss-leader for them - waste of time," he said.

"We are going to have a situation in the UK where drugs are not available for our patients. It is a disaster. Someone just needs to sort this out."

A Department of Health spokesman said: "The Government has increased spending on health, which includes new drugs, and thousands more patients are getting access to the most advanced treatments.

"This includes the 11,000 extra patients who have benefited from the setting up of our £650 million Cancer Drugs Fund.

"The need for careful assessment of drugs' effectiveness by Nice is particularly important for patients and taxpayers during a time of economic austerity.

"The Government has not changed any assessment processes relating to cancer drugs.

"Furthermore, drug companies need to look hard at the high costs they are asking of the health service for their latest treatments."

PA

PROMOTED VIDEO
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Life and Style
ebooksFrom the lifespan of a slug to the distance to the Sun: answers to 500 questions from readers
News
video
Sport
Malky Mackay salutes the Cardiff fans after the 3-1 defeat at Liverpool on Sunday
footballFormer Cardiff boss accused of sending homophobic, racist and messages
Arts and Entertainment
Martin Amis: Taken to task over rash decisions and ill-judged statements
booksThe Zone of Interest just doesn't work, says James Runcie
Life and Style
life – it's not, says Rachel McKinnon
Arts and Entertainment
Eye of the beholder? 'Concrete lasagne' Preston bus station
architectureWhich monstrosities should be nominated for the Dead Prize?
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Service Desk Analyst- Desktop Support, Helpdesk, ITIL

    £20000 - £27000 per annum: Harrington Starr: Service Desk Analyst- (Desktop Su...

    Service Desk Engineer-(Support, ITIL, Software Vendor)

    £30000 - £35000 per annum: Harrington Starr: Service Desk Engineer-(Support, S...

    Trainee Recruitment Consultant

    £18000 - £30000 per annum + uncapped: SThree: Do you feel you sales role is li...

    Trainee Recruitment Consultant

    £20000 - £45000 per annum + uncapped: SThree: Key featuresA highly motivated ...

    Day In a Page

    Middle East crisis: We know all too much about the cruelty of Isis – but all too little about who they are

    We know all too much about the cruelty of Isis – but all too little about who they are

    Now Obama has seen the next US reporter to be threatened with beheading, will he blink, asks Robert Fisk
    Neanderthals lived alongside humans for centuries, latest study shows

    Final resting place of our Neanderthal neighbours revealed

    Bones dated to 40,000 years ago show species may have died out in Belgium species co-existed
    Scottish independence: The new Scots who hold fate of the UK in their hands

    The new Scots who hold fate of the UK in their hands

    Scotland’s immigrants are as passionate about the future of their adopted nation as anyone else
    Britain's ugliest buildings: Which monstrosities should be nominated for the Dead Prize?

    Blight club: Britain's ugliest buildings

    Following the architect Cameron Sinclair's introduction of the Dead Prize, an award for ugly buildings, John Rentoul reflects on some of the biggest blots on the UK landscape
    eBay's enduring appeal: Online auction site is still the UK's most popular e-commerce retailer

    eBay's enduring appeal

    The online auction site is still the UK's most popular e-commerce site
    Culture Minister Ed Vaizey: ‘lack of ethnic minority and black faces on TV is weird’

    'Lack of ethnic minority and black faces on TV is weird'

    Culture Minister Ed Vaizey calls for immediate action to address the problem
    Artist Olafur Eliasson's latest large-scale works are inspired by the paintings of JMW Turner

    Magic circles: Artist Olafur Eliasson

    Eliasson's works will go alongside a new exhibition of JMW Turner at Tate Britain. He tells Jay Merrick why the paintings of his hero are ripe for reinvention
    Josephine Dickinson: 'A cochlear implant helped me to discover a new world of sound'

    Josephine Dickinson: 'How I discovered a new world of sound'

    After going deaf as a child, musician and poet Josephine Dickinson made do with a hearing aid for five decades. Then she had a cochlear implant - and everything changed
    Greggs Google fail: Was the bakery's response to its logo mishap a stroke of marketing genius?

    Greggs gives lesson in crisis management

    After a mishap with their logo, high street staple Greggs went viral this week. But, as Simon Usborne discovers, their social media response was anything but half baked
    Matthew McConaughey has been singing the praises of bumbags (shame he doesn't know how to wear one)

    Matthew McConaughey sings the praises of bumbags

    Shame he doesn't know how to wear one. Harriet Walker explains the dos and don'ts of fanny packs
    7 best quadcopters and drones

    Flying fun: 7 best quadcopters and drones

    From state of the art devices with stabilised cameras to mini gadgets that can soar around the home, we take some flying objects for a spin
    Joey Barton: ‘I’ve been guilty of getting a bit irate’

    Joey Barton: ‘I’ve been guilty of getting a bit irate’

    The midfielder returned to the Premier League after two years last weekend. The controversial character had much to discuss after his first game back
    Andy Murray: I quit while I’m ahead too often

    Andy Murray: I quit while I’m ahead too often

    British No 1 knows his consistency as well as his fitness needs working on as he prepares for the US Open after a ‘very, very up and down’ year
    Ferguson: In the heartlands of America, a descent into madness

    A descent into madness in America's heartlands

    David Usborne arrived in Ferguson, Missouri to be greeted by a scene more redolent of Gaza and Afghanistan
    BBC’s filming of raid at Sir Cliff’s home ‘may be result of corruption’

    BBC faces corruption allegation over its Sir Cliff police raid coverage

    Reporter’s relationship with police under scrutiny as DG is summoned by MPs to explain extensive live broadcast of swoop on singer’s home